Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
OTC Markets EXMKT - Delayed Quote USD

eFFECTOR Therapeutics, Inc. (EFTR)

Compare
0.0002
0.0000
(0.00%)
At close: April 1 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
--
42,000
Operating Expense
32,704
33,844
32,403
31,897
26,181
Operating Income
-32,704
-33,844
-32,403
-31,897
15,819
Net Non Operating Interest Income Expense
-1,910
-1,947
-1,812
-1,758
-1,266
Other Income Expense
-17
-20
11,550
49,453
9
Pretax Income
-34,631
-35,811
-22,665
15,798
14,562
Tax Provision
--
--
--
--
351
Net Income Common Stockholders
-34,631
-35,811
-22,665
15,798
166
Average Dilution Earnings
--
--
--
--
133
Diluted NI Available to Com Stockholders
-34,631
-35,811
-22,665
15,798
299
Basic EPS
-12.57
-16.37
-13.76
26.25
0.10
Diluted EPS
-12.57
-16.37
-13.76
11.00
0.10
Basic Average Shares
2,787.3410
2,186.9540
1,647.1830
604.2340
1,614.7740
Diluted Average Shares
2,787.3410
2,186.9540
1,647.1830
1,440.1620
1,614.7740
Total Operating Income as Reported
-32,704
-33,844
-32,403
-31,897
15,819
Total Expenses
32,704
33,844
32,403
31,897
26,181
Net Income from Continuing & Discontinued Operation
-34,631
-35,811
-22,665
15,798
14,211
Normalized Income
-34,637
-35,817
-34,789
-19,547.1400
14,211
Interest Income
1,069
972
439
6
67
Interest Expense
2,979
2,919
2,251
1,764
1,333
Net Interest Income
-1,910
-1,947
-1,812
-1,758
-1,266
EBIT
-31,652
-32,892
-20,414
17,562
15,895
EBITDA
-31,541
-32,781
-20,361
17,586
16,055
Reconciled Depreciation
111
111
53
24
160
Net Income from Continuing Operation Net Minority Interest
-34,631
-35,811
-22,665
15,798
14,211
Total Unusual Items Excluding Goodwill
6
6
12,124
48,418
--
Total Unusual Items
6
6
12,124
48,418
--
Normalized EBITDA
-31,547
-32,787
-32,485
-30,832
16,055
Tax Rate for Calcs
--
--
--
0.0003
0
Tax Effect of Unusual Items
--
--
--
13,072.8600
--
12/31/2020 - 8/27/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CALA Calithera Biosciences, Inc.
0.0001
-80.00%
 
BVAXF BioVaxys Technology Corp.
0.0354
0.00%
 
ARCH.V Arch Biopartners Inc.
1.7000
-3.41%
 
RNXT RenovoRx, Inc.
0.9600
-3.03%
 
NEXI NexImmune, Inc.
0.0001
0.00%
 
JSPR Jasper Therapeutics, Inc.
4.1400
-3.72%
 
LIXT Lixte Biotechnology Holdings, Inc.
1.1950
-1.24%
 
PALI Palisade Bio, Inc.
0.6698
-1.62%
 
BIOR Biora Therapeutics, Inc.
0.2200
0.00%
 
ADIL Adial Pharmaceuticals, Inc.
0.6560
+3.44%